baber/WOPTO huggingface dataset:
Patent DK-1538202-T3 (DK)
Inventor: SELDEN RICHARD F
IPC: A61P1/14
Filed: 1997-09-12
Granted: 2014-03-24
Abstract: The present invention provides a process for purifying human ±-galactosidase A (±-gal A) from a sample, wherein the process comprises a first chromatography step wherein the sample is passed over a hydrophobic interaction resin.
Patent DK-1608904-T3 (DK)
Inventor: DUPOIRON FRANCOIS
IPC: F16L11/08
Filed: 2004-03-16
Granted: 2007-02-05
Abstract: The pipe has an internal annular space (30) between a pressure sleeve and an intermediate sleeve and a layer (13) allowing drainage of the gases present in the annular space. The layer is made by coiling at short pitch a long element containing transverse drainage spaces or hollows which allow drainage transversely between the successive turns of the coil. The pipe has, from the inside to the outside, a pressure sleeve (2), a pressure vault (3) containing at least one pressure resistance armor, an intermediate sleeve and at least one traction armor layer (5, 6). The long element coiled to form the drainage layer is a shaped wire or made of a preformed metal sheet or formed by a hoop around the pressure resistance armor. The angle of winding of the long element is greater than 70[deg]. The long element contains transverse hollows spread longitudinally so they are aligned at least partially with another hollow once the coiling is complete, to form transverse drainage channels. The long element has a longitudinal space designed to allow the circulation of gas inside the same turn and is made entirely or partially of polymer material. The drainage layer is made by winding two different long elements.
Patent DK-1635828-T3 (DK)
Inventor: BANG-ANDERSEN BENNY
IPC: C07D409/12
Filed: 2004-04-02
Granted: 2008-08-11
Abstract: The invention provides compounds represented by the general formula (I) wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder, including depression, anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.
Patent DK-1648431-T3 (DK)
Inventor: MOULINOUX JACQUES-PHILIPPE
IPC: A23L33/00
Filed: 2004-07-22
Granted: 2009-09-14
Abstract: The use of a human food composition (A) containing less than 1600 picomoles per g of polyamines (I) is claimed in the production of a therapeutic food for combating syndromes or disorders involving the NR2-N subunit of the N-methyl-D-aspartate (NMDA) receptor. ACTIVITY : Analgesic; Vasotropic; Neuroprotective; Nootropic; Antiparkinsonian; Anticonvulsant; Virucide; Antimanic; Antidepressant; Neuroleptic; Antiaddictive; Auditory. In tests in rats fed (a) a solid diet with a very low polyamine (I) content of less than 10 mu g/kg or (b) the same diet supplemented with the polyamines putrescine (54 mg/kg), spermine (7 mg/kg) and spermidine (7 mg/kg) (i.e. the levels present in normal rodent feed), the sensitivity to pain caused by two injections (7 days apart) of carrageenan into the paw was measured by the Randall-Selitto test. The level of pain in the days following the second injection was markedly lower in group (a) than that in group (b), demonstrating that the low-(I) diet in group (a) reduced the sensitivity to pain. The levels of pain in the days following the first injection were not significantly different, demonstrating the low-(I) diet had no direct analgesic effect. MECHANISM OF ACTION : NMDA receptor NR2-N subunit modulator.
Patent DK-1664016-T3 (DK)
Inventor: SUN QUN
IPC: C07D417/04
Filed: 2004-09-21
Granted: 2009-02-23
Abstract: The present invention discloses a compound of formula: where Ar1, Ar2, X, Z1, Z2, R3, and m are as disclosed herein or a pharmaceutically acceptable salt thereof (a “Pyridylene Compound”); compositions comprising an effective amount of a Pyridylene Compound; and methods for treating or preventing pain or other conditions in an animal comprising administering to an animal in need thereof an effective amount of a Pyridylene Compound.
Patent DK-1692251-T3 (DK)
Inventor: KOCH HERBERT
IPC: C11D11/00
Filed: 2004-12-10
Granted: 2009-03-23
Abstract: A method for inhibiting or minimizing dye redeposition in decolorization of a dyed fabric containing cotton fibers involves contacting the fabric during the process with a redeposition inhibitor consisting of a polyester (I), obtained from (a) dicarboxylic acids, (b) 2-6C diols and (c) polyether alcohols containing 1 or 2 OH groups and at least 6 O atoms, were (a), (b) and (c) form more than 80 wt. % of the monomers incorporated in (I).
Patent DK-1790521-T3 (DK)
Inventor: SCHNIERLE MARTIN
IPC: B64D11/06
Filed: 2006-10-07
Granted: 2009-09-14
Abstract: The support has a base plate (1), where a number of guide pins (2) projects downwards, for engagement into guide grooves (3) of a base rail (4) and axially adjustable locking pins (17) for engagement into locking openings of the base rail and for axial restraining of the guide pins within the guide grooves are arranged in the base plate. The locking pins have a lower pivot for engagement into the locking openings and an upper ring flange for supporting at the top side of the base rail. The locking pins are axially adjusted by a lever arrangement.
Patent DK-2149308-T3 (DK)
Inventor: WEST LESLIE
IPC: A23L29/00
Filed: 2009-07-30
Granted: 2012-01-30
Abstract: Comestibles including nicotianamine as a natural replacer for EDTA and methods of use thereof are provided.
Patent DK-2221620-T3 (DK)
Inventor: YALKINOGLU OEZKAN DR
IPC: G01N33/53
Filed: 2003-08-11
Granted: 2014-01-06
Abstract: A method for assessing the state of Alzheimer's disease in patients is disclosed. A method for monitoring the progression of Alzheimer's disease in patients is also disclosed. The method applies detection of specific markers in body fluids (e.g. CSF), using mass spectrometric analysis (SELDI-TOF MS). The specific markers are: human cystatin C, human beta-2-microglobulin, human myoglobin neurosecretory protein VGF or fragments of these proteins.
Patent DK-2488237-T3 (DK)
Inventor: KRULEVITCH PETER
IPC: A61M5/32
Filed: 2010-10-15
Granted: 2018-08-27
Abstract: Disclosed is a device for the parenteral delivery of a medication, such as a drug. The device includes upper and lower housings in which the upper housing is configured to move relative to the lower housing as a result of application of an external force to permit the user of the device to control the rate at which the drug is administered.
Patent DK-0396908-T3 (DK)
Inventor: ESSER ANTON
IPC: F23H1/02
Filed: 1990-04-05
Granted: 1994-09-19
Abstract: In known grate furnaces, the air slots between the individual grate bars are aligned perpendicularly to the grate surface. The primary air flowing through thus forms jets directed perpendicularly upwards. A new grate bar (4) has been developed, in which the cross-section of the grate bar head (6) has a shape similar to a rhomboid. In a furnace grate, which is equipped with grate bars (4) of this type, the primary air jets emerge at an angle. Surprisingly, it has been found that the utilisation of the primary air is consequently significantly improved. The grate bar (4) is particularly suitable for use in roller grate furnaces of waste incineration installations. 
<IMAGE>
Patent DK-0390438-T3 (DK)
Inventor: BEYTS PAMELA KAY
IPC: A23L27/30
Filed: 1990-03-23
Granted: 1993-01-11
Abstract: Sweetening synergy is is obtained by combining sucralose and isomaltulose.
Patent DK-0460042-T3 (DK)
Inventor: ECCLES SARAH JANE FLAT WOODLAN
IPC: C12N15/85
Filed: 1990-02-22
Granted: 2000-07-31
Abstract: A vector for the integration of a gene into the genetic material of a mammalian host cell such that the gene may be expressed by the host cell. The vector comprises a promoter and the gene and an immunoglobulin dominant control region derived from the mouse  lambda immunoglobulin gene locus capable of eliciting host cell-type restricted, integration site independent, copy number dependent expression of the said gene. The DNaseI super hypersensitive site exemplified are i) about 2.35kb upstream of the CAP site of the rearranged  lambda 1 gene ii) about 2.5kb upstream of the genomic V lambda 2 segment or iii) about 30kb downstream of the rearranged lambda 1 gene. Mammalian host cells transformed with the vector are disclosed as are transgenic mammals transformed with the vector and a method of producing a polypeptide comprising culturing a transformed mammalian cell. A method of gene therapy comprising the steps of i) removing stem cells from the body of a mammal, ii) optionally killing stem cells remaining in the body, iii) transforming the removed stem cells with the vector containing a gene deficient or absent in the body, and iv) replacing the transformed stem cells in the body is also disclosed. Also disclosed is functional mouse immunoglobulin  lambda 1 enhancer consisting of a DNA sequence comprising all or a functional part of the DNA sequence between the EcoRI site 3.8 kb downstream of the Xho I site in the rearranged mouse  lambda 1 gene and the SnaBI site 10 kb downstream of this Xho I site. The functional mouse immunoglobulin lambda 1 enhancer may comprise all or a functional part of i) the 1.3 kb first HindIII to HindIII DNA fragment downstream of the EcoRI site 3.8 kb downstream of the Xho I site in the rearranged mouse  lambda 1 gene, ii) the 3.3 kb HindIII to HindIII DNA fragment downstream of the EcoRI site 3.8 kb downstream of the Xho I site in the rearranged mouse  lambda 1 gene and spanning the SnaBI site 10 kb downstream of this Xho I site.
Patent DK-0464161-T3 (DK)
Inventor: HEIER ANDREAS
IPC: C03B37/15
Filed: 1990-11-12
Granted: 1994-05-30
Abstract: The invention concerns a process and device for eliminating the play between the outer surface of an optical fibre (1) and the inner surface of the bore (22) in an optical-fibre mounting (2). The process proposed does not attempt to adapt the zone surrounding the optical fibre to the external shape of the fibre, as used to be the case, but adapts the optical fibre to the internal shape of the bore (22). The process steps necessary for this include heating the optical fibre (1), then compressing it longitudinally and pulling the compressed section (11) into the mounting (2), bonding the optical fibre (1) with adhesive (7) in the bore (22) and finally, in a separate operation, abrading/polishing the end (12) of the optical fibre and the end (23) of the mounting (2). The process can be used anywhere where the optical fibre can be adapted to the internal shape of the mounting bore by heating and compressing.
Patent DK-0440059-T3 (DK)
Inventor: GASS RAYMOND
IPC: H04J3/00
Filed: 1991-01-21
Granted: 1994-11-21
Abstract: A first channel of each frame is reserved for management data independent of the information to be transmitted, second channels of each frame in the course of a multiframe are reserved for route service data which are divided up into a first group of a specified number of second channels with specified ranks, reserved for the service bytes of the asynchronous information transmission cells, and into a second group of second channels which specify the number of isochronous information transmission channels exploited in the course of the frame of which each of them forms a part. The third channel of each of the successive frames is at least partly reserved for a code defining a start-of-cell channel rank for every cell appearing in the course of the relevant frame.
Patent DK-0512143-T3 (DK)
Inventor: STORM JUERGEN ING-GRAD
IPC: H04L12/56
Filed: 1991-05-08
Granted: 1996-11-11
Abstract: Because of the fact that the bit rates in each connection differ greatly in broadband switching systems, the control capacity needed for each broadband connection can fluctuate by more than three orders of magnitude. To achieve uniform load distribution between the group processors in view of this fluctuating demand for control capacity, the allocation of the access modules to the group processors can be varied during the operation of the switching system. <IMAGE>
Patent DK-0541858-T3 (DK)
Inventor: ORBAN ERNO DR
IPC: A61K33/06
Filed: 1991-11-19
Granted: 1998-02-02
Abstract: The invention relates to a novel oil-in-water type cream containing aluminum potassium sulfate, which is useful for the treatment of varicosity. The composition of the invention contains 1 to 15 % by weight of pharmaceutically acceptable lipid-type ointment base, 0 to 10 % by weight of propylene glycol and 0.1 to 5.0 % by weight of cetyltrimethylammonium bromide and/or cetyltrimethylammonium chloride as emulsifying agent.
Patent DK-0504781-T3 (DK)
Inventor: PLANCK HEINRICH DIPL-ING DR
IPC: A61F2/02
Filed: 1992-03-17
Granted: 1997-07-28
Abstract: The invention relates to a bio-hybrid hollow organ having chambers (2) with porous chamber walls for reception of organelles (3). The bio-hybrid hollow organ is structurally designed such that it can be arranged in the region of a wall (1) in a conductor track of the receiver or replaces a corresponding wall section. The walls of the chambers (2) directed toward the interior of the conductor track are designed as porous membranes which permit material transfer by diffusion in a liquid flowing in the conductor track or vice versa. The hollow organ is preferably designed as a vascular prosthesis. <IMAGE>
Patent DK-0578711-T3 (DK)
Inventor: PARKES SIMON
IPC: B65D85/72
Filed: 1992-04-07
Granted: 1998-02-02
Abstract: A container for beer and other beverages has a plastics material body (2) closed by way of an end closure (10). When the container is opened by removing the closure (10), the body member (2) defines a drinking vessel having an unrestricted mouth opening (6). This obviates the need to dispense the contents of the container into a further vessel. In order to contain beer and other carbonated beverages, the body member (2) is made of nylon and PET laminated together. A shrink wrap label (16) may be applied externally of the body member (2) to identify both the contents of the container and to bear customised information as to the occasion at which the containers are provided.
Patent DK-0603215-T3 (DK)
Inventor: BISHOP PAUL D
IPC: C12N15/09
Filed: 1992-08-07
Granted: 1997-12-01
Abstract: Highly purified factor XIII and methods of purifying factor XIII are disclosed. Factor XIII is purified from a biological fluid, such as a cell lysate. The methods provide factor XIII compositions that are greater than 99 % pure with respect to contaminating proteins. The methods further provide factor XIII compositions wherein 1 % or less of the factor XIII is activated factor XIII.
Patent DK-0587062-T3 (DK)
Inventor: NAWOTKA OTFRIED
IPC: C09D109/06
Filed: 1993-09-03
Granted: 1998-01-26
Abstract: Aqueous filling pastes are described which contain at least one water-dilutable, olefinically unsaturated binder, conventional pigments, fillers and additives corresponding to a solids content of 50 - 90 % by weight, 10 - 40 % by weight of water and 0 - 10 % by weight of one or more organic solvents, the water-dilutable, olefinically unsaturated binders containing anionic groups or groups which can be converted to anionic groups, corresponding to an acid number of 25 - 175, and being reaction products of     A) 40 - 80 % by weight of one or more polydiene oils, B) 5 - 25 % by weight of one or more polymerisable, olefinically unsaturated monomers which contain anionic groups or groups which can be converted into anionic groups,   C) 0 - 10 % by weight of one or more bis(2-oxazolines), and D) 0 - 40 % by weight of one or more ethylenically unsaturated monomers  the % by weight of A), B), C) and D) adding up to 100 % by weight. The filling pastes can be used in processes for producing multi-coat finishes, especially in the vehicles sector.
Patent DK-0619809-T3 (DK)
Inventor: DORAN HENRY J
IPC: A61P25/04
Filed: 1992-12-16
Granted: 1995-12-04
Abstract: Prepn. of flunixin, i.e. 2-((2-methyl-3-(trifluoromethyl) phenyl)amino)-3-pyridine carboxylic acid (I), and its pharmaceutically acceptable salts, comprises: (a) methylating a cpd. of formula (III) to give (V); (b) (i) for (V) where Z = a halo blocking gp., either contacting (V) with a reducing agent to give cpd. (VI), and hydrolysing (VI) with acid to give 2-methyl-3-trifluoroaniline (MTA); or hydrolysing (V) with acid to give cpd. (VII), and contacting (VII) with a reducing agent to give MTA; or (ii) for (V) where Z=H, sepg. (VI) from the reaction mixt. and hydrolysing it with acid to give MTA; or hydrolysing the reaction mixt. with acid and sepg. out MTA; and (c) converting MTA to (I) or its salt. In the formulae, Z = H or a halo blocking gp.; Z1 = a halo blocking gp.
Patent DK-0654085-T3 (DK)
Inventor: PLUECKTHUN ANDREAS
IPC: C07K14/39
Filed: 1993-01-15
Granted: 1997-09-22
Abstract: PCT No. PCT/EP93/00082 Sec. 371 Date Jul. 22, 1994 Sec. 102(e) Date Jul. 22, 1994 PCT Filed Jan. 15, 1993 PCT Pub. No. WO93/15210 PCT Pub. Date Aug. 5, 1993The present invention describes a new class of antigen binding molecules which contain Fv-fragments of an antibody but do not use the constant antibody domains. They can also dimerize with other antibody fragment molecules or with non-antibody fragment molecules to form bi- or multifunctional antibody-fragment fusion proteins and so-called miniantibodies, respectively. The new fusion proteins can be used in the broad field of diagnostic and therapeutical medicine.
Patent DK-0624199-T3 (DK)
Inventor: HOLLY RICHARD D
IPC: A61P7/04
Filed: 1992-12-30
Granted: 1999-11-01
Abstract: Methods are disclosed for producing thrombin. The protein is produced from host cells transformed or transfected with DNA construct(s) containing information necessary to direct the expression of thrombin precursors. The DNA constructs generally include the following operably linked elements: a transcriptional promoter, DNA sequence encoding a gla-domainless prothrombin, and a transcriptional terminator. Thrombin precursors produced from transformed or transfected host cells are activated either in vivo or in vitro.
Patent DK-0643663-T3 (DK)
Inventor: CARLSSON ROLF ARNE
IPC: B65D5/468
Filed: 1993-06-04
Granted: 1997-10-13
Abstract: A packaging unit for sheet like material such as paper, comprises a box (1) provided with a lid (2), both of rectangular configuration and including a center part, two side parts and two end walls parts which are easily dismountable. Each box end wall part (4) has an additional end wall part (3) which is mounted externally of the first mentioned end wall part (4) and has a generally rectangular configuration and an area which is 70-100% of the actual area of the inwardly lying end wall part (4). The additional end wall part (3) is fastened at least partially to the lower region of the inwardly lying end wall part (4) and the additional end wall part (3) is provided in its upper half with a foldable lip (7) from which material has been removed on at least one side (5,6). The lip (7) enables the uppermost part of the additional end wall part (3) to be folded outwardly of the lid end wall part and subsequent to being folded, functions to strengthen and protect the resultant gripping aperture.
Patent DK-0618234-T3 (DK)
Inventor: UNGARELLI FABRIZIO
IPC: C08B37/00
Filed: 1994-03-18
Granted: 1997-08-25
Abstract: A process for the synthesis of semi-synthetic glycosaminoglycans of general formula III <CHEM> with heparin or heparan structure modified in position 2 of the alpha -L-iduronic-2-O-sulfate acid in which the sulfate group is, entirely or in part, substituted with a nucleophilic radical is described. Said process is carried out by treating glycosaminoglycans with heparin or heparan structure by means of a nucleophilic agent in alkaline medium.
Patent DK-0684760-T3 (DK)
Inventor: YOUNG STUART DOUGLAS
IPC: A47C27/12
Filed: 1994-01-17
Granted: 2000-09-04
Abstract: PCT No. PCT/CA94/00019 Sec. 371 Date Jul. 18, 1995 Sec. 102(e) Date Jul. 18, 1995 PCT Filed Jan. 17, 1994 PCT Pub. No. WO94/15452 PCT Pub. Date Jul. 21, 1994In an animal stall, a brisket board extends along the front end portion of the floor, and a keeper board extends along the rear portion of the floor. An animal mattress is disposed on the floor between the brisket board and the keeper board, with the mattress extending over the keeper board. The mattress includes a fabric enclosure having a plurality of separate compartments within the enclosure, and comminuted rubber from used vehicle tires is disposed within each compartment. A top fabric blanket is disposed over the mattress with an end of the blanket attached to the keeper board, and an opposed end of the blanket attached to the brisket board.
Patent DK-0697931-T3 (DK)
Inventor: TRUEBENBACH PETER
IPC: C04B35/638
Filed: 1994-01-12
Granted: 1997-04-28
Abstract: PCT No. PCT/EP94/00072 Sec. 371 Date Aug. 10, 1995 Sec. 102(e) Date Aug. 10, 1995 PCT Filed Jan. 12, 1994 PCT Pub. No. WO94/25205 PCT Pub. Date Nov. 10, 1994Sintered moldings are produced by molding a mixture of a sinterable ceramic or metallic powder and polyoxymethylene or a copolymer containing a majority of oxymethylene units as binder to give a compact, removing the binder by treatment with a gaseous acid, and sintering the product, which comprises removing the binder using an acid which is solid at room temperature and sublimes or melts and evaporates at elevated temperatures.
Patent DK-0725653-T3 (DK)
Inventor: ROBERTS MARK
IPC: C07K14/235
Filed: 1994-10-04
Granted: 2004-10-11
Abstract: The invention relates to the use of an antigen which is a non-toxic double mutant form of pertussis toxin for the manufacture of a vaccine composition for intranasal administration to induce an immune response against B. pertussis infection. The invention also relates to the use of a non-toxic double mutant form of pertussis toxin for the manufacture of an adjuvant composition for stimulating or enhancing a protective immune response of an antigen co-administered therewith. The non-toxic double mutant is preferably one in which the glutamic acid 129 amino acid in the S1 sub-unit has been substituted by glycine and the arginine 9 amino acid has been substituted by lysine.
Patent DK-0706944-T3 (DK)
Inventor: BO ANDERSSON
IPC: B65B31/04
Filed: 1995-05-04
Granted: 1996-12-02
Abstract: A process for introducing an aroma into the headspace of a package containing a food product during the gas packaging of the food product which comprises introducing a modified atmosphere into the headspace, and introducing a food acceptable aroma dissolved in a liquid food acceptable gas under pressure into the headspace of the package. <IMAGE>
Patent DK-0691539-T3 (DK)
Inventor: JOHNSON LARRY D
IPC: G01N27/327
Filed: 1995-06-14
Granted: 2007-04-02
Abstract: A method of making and an amperometric electrode are provided. An electrode carbon ink is applied to a polymer substrate to form a working electrode. The substrate carrying the working electrode is placed in a gas plasma cleaner, such as an oxygen or nitrogen plasma, to clean the working electrode. A high radio frequency signal excites the gas plasma for a short exposure time in a range between 10 seconds and 30 seconds. Then a reagent layer is deposited to the plasma treated working electrode.